Amy Baxter is a clinical associate professor of emergency medicine at Augusta University, federally funded for neuromodulation research to reduce needle pain, multimodal low back pain, and opioid reduction. After attending Yale University and Emory Medical School, she completed her residency and a child maltreatment fellowship at Cincinnati Children's Hospital Medical Center, an emergency pediatrics fellowship in Norfolk, Virginia, and a K30-NIH Clinical Research Certificate at UT Southwestern Medical Center. She is also CEO, Pain Care Labs, and can be reached on Twitter @AmyBaxterMD.

As a founding member of the Society for Pediatric Sedation, her scientific service includes over 20 review sections for NIDA, NICHD, and NINDS. Her contributions include the development of the hepatic enzyme algorithm for timing child abuse, the creation and validation of the BARF nausea scale for pediatric oncology, identifying the cause and consequences of needle fear, demonstrating reduced COVID-19 morbidity and mortality with nasal irrigation, and holding 12 patents on thermomechanical stimulation to reduce pain and promote healing. She also lectures internationally on pain, opioid use, health tech innovation, procedural pain management, and needle fear.